inhaled voriconazole
Term · Oncology and biomedicine · MLC-T-ONC-014454
An inhaled formulation of voriconazole, a synthetic triazole with antifungal activity. Upon administration by inhalation, voriconazole selectively inhibits 14-alpha-lanosterol demethylation in fungi, preventing the production of ergosterol, an essential constituent of the fungal cell membrane, and resulting in fungal cell lysis.
| Identifier | MLC-T-ONC-014454 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014454",
"term": "inhaled voriconazole",
"field": "Oncology and biomedicine",
"definition": "An inhaled formulation of voriconazole, a synthetic triazole with antifungal activity. Upon administration by inhalation, voriconazole selectively inhibits 14-alpha-lanosterol demethylation in fungi, preventing the production of ergosterol, an essential constituent of the fungal cell membrane, and resulting in fungal cell lysis.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/inhaled-voriconazole/"
}
Record 9,268 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.